CDK4 and hepatocellular carcinoma: Since the reconstitution of YAP1 could not completely restore the malignant phenotypes caused by the inhibition of CDK4/6 in HCC cells, it is noteworthy that we cannot rule out the possibility of additional mechanisms involved in CDK4/6-mediated tumor progression of HCC.